MedPath

Effect of topical vitamin D3 in pressure ulcer

Not Applicable
Recruiting
Conditions
Stage 1 or 2 pressure ulcer.
Pressure ulcer
Registration Number
IRCT20230317057747N1
Lead Sponsor
Hamedan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

Patients admitted to Hamedan Shahid Beheshti Hospital
Bedsore diagnosis based on patients's body observational studies
Grade 1 or 2 pressure ulcer according to the 2_digit stirling scale method

Exclusion Criteria

Grade 3 or 4 pressure ulcer at baseline
Inability to follow up the study for 14 days
Hypersensitivity history to the formulation
Confirmed or suspected acute wound infection
No interest of entering the study

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The percentage of wound size change on the seventh and fourteenth days of the intervention. Timepoint: Measurement of wound surface area at the beginning of the study ( before the start of the intervention) and 7 and 14 days after starting the intervention. Method of measurement: Imaging the surface of the wound with a camera and then calculating its area in Image J in software.
Secondary Outcome Measures
NameTimeMethod
The number of patients without erythema around the wound. Timepoint: At the beginning of the study (before the start of the intervention) and 7 and 14 days after starting the intervention. Method of measurement: Visual observation.;The number of cases with complete wound healing. Timepoint: Days 7 and 14 after the start of the intervention. Method of measurement: Measurement the surface area at the wound at the beginning of the study ( before the start of the intervention) and 7 and 14 days after its start and observing cases of more than 90% reduction in the size of the wound.
© Copyright 2025. All Rights Reserved by MedPath